Post-marketing requirements (PMR) for this BLA included the establishment and qualification of a Working Cell Bank (WCB) to ensure consistent production quality. 2. Technical & Hardware: Linear Technology DC1255A
, with the Biologics License Application (BLA) number 125516 , is an orphan drug developed by United Therapeutics . 125516
In the field of electrical engineering, refers to a specific demonstration circuit for 16-bit analog-to-digital converters (ADCs). Device: DC1255A is a 16-bit demonstration circuit. Post-marketing requirements (PMR) for this BLA included the